B7-H1 Antigen
/ biosynthesis
Central Nervous System Neoplasms
/ genetics
Cyclin-Dependent Kinase Inhibitor p16
/ genetics
Female
Gene Dosage
Humans
Lymphoma, Large B-Cell, Diffuse
/ genetics
Male
Middle Aged
Mutation
Myeloid Differentiation Factor 88
/ genetics
NF-kappa B
/ metabolism
Up-Regulation
Exome Sequencing
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
12 02 2019
12 02 2019
Historique:
received:
23
10
2018
accepted:
11
12
2018
entrez:
7
2
2019
pubmed:
7
2
2019
medline:
6
2
2020
Statut:
ppublish
Résumé
The genetic alterations that define primary central nervous system lymphoma (PCNSL) are incompletely elucidated, and the genomic evolution from diagnosis to relapse is poorly understood. We performed whole-exome sequencing (WES) on 36 PCNSL patients and targeted
Identifiants
pubmed: 30723112
pii: bloodadvances.2018027672
doi: 10.1182/bloodadvances.2018027672
pmc: PMC6373750
doi:
Substances chimiques
B7-H1 Antigen
0
CD274 protein, human
0
CDKN2A protein, human
0
Cyclin-Dependent Kinase Inhibitor p16
0
MYD88 protein, human
0
Myeloid Differentiation Factor 88
0
NF-kappa B
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
375-383Subventions
Organisme : NCI NIH HHS
ID : P30 CA006973
Pays : United States
Informations de copyright
© 2019 by The American Society of Hematology.
Références
Acta Neuropathol. 2016 Jun;131(6):865-75
pubmed: 26757737
Hum Pathol. 2014 Mar;45(3):556-64
pubmed: 24444466
Cancer Discov. 2017 Sep;7(9):1018-1029
pubmed: 28619981
N Engl J Med. 2012 Jun 28;366(26):2443-54
pubmed: 22658127
Clin Cancer Res. 2012 Oct 1;18(19):5203-11
pubmed: 22837180
Bioinformatics. 2011 Sep 15;27(18):2601-2
pubmed: 21803805
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Blood Cancer J. 2013 Sep 06;3:e139
pubmed: 24013661
Blood. 2016 Feb 18;127(7):869-81
pubmed: 26702065
Hematol Oncol. 2017 Dec;35(4):487-496
pubmed: 27966264
Clin Cancer Res. 2015 Sep 1;21(17):3986-94
pubmed: 25991819
Acta Neuropathol. 2011 Dec;122(6):791-2
pubmed: 22020631
Br J Haematol. 2015 Jul;170(2):285-7
pubmed: 25643939
Am J Clin Pathol. 1998 Nov;110(5):607-12
pubmed: 9802345
Blood. 2014 Jan 23;123(4):486-93
pubmed: 24282217
Clin Neuropathol. 2014 Jan-Feb;33(1):42-9
pubmed: 24359606
Cancer Discov. 2015 Nov;5(11):1164-1177
pubmed: 26410082
Genome Biol. 2011;12(4):R41
pubmed: 21527027
Nat Biotechnol. 2012 May;30(5):413-21
pubmed: 22544022
J Clin Oncol. 2016 Sep 1;34(25):2980-7
pubmed: 27354485
Neuropathol Appl Neurobiol. 2016 Apr;42(3):279-90
pubmed: 26111727
Pathol Int. 2015 Oct;65(10):528-35
pubmed: 26388135
Cancer Cell. 2017 Jun 12;31(6):833-843.e5
pubmed: 28552327
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Sci Rep. 2017 May 11;7(1):1785
pubmed: 28496180
Oncotarget. 2014 Jul 15;5(13):5065-75
pubmed: 24970810
Br J Cancer. 2011 Oct 25;105(9):1414-8
pubmed: 21915121
Nat Med. 2015 Aug;21(8):922-6
pubmed: 26193343
Leuk Lymphoma. 2015 Jul;56(7):2141-5
pubmed: 25347427
Hum Pathol. 2013 Jul;44(7):1375-81
pubmed: 23380077
Nature. 2011 Feb 3;470(7332):115-9
pubmed: 21179087
Nature. 2011 Feb 10;470(7333):214-20
pubmed: 21307934
Br J Haematol. 2016 Aug;174(3):417-24
pubmed: 27018254
Nature. 2010 Jan 7;463(7277):88-92
pubmed: 20054396
Nat Genet. 2015 Sep;47(9):1047-55
pubmed: 26192918
Biostatistics. 2004 Oct;5(4):557-72
pubmed: 15475419
Clin Cancer Res. 2013 Jul 1;19(13):3462-73
pubmed: 23674495
Lancet Oncol. 2018 May;19(5):672-681
pubmed: 29602646
Bioinformatics. 2012 Jul 15;28(14):1811-7
pubmed: 22581179
World Neurosurg. 2018 Apr;112:e69-e73
pubmed: 29258950
Cancer. 1994 Aug 15;74(4):1383-97
pubmed: 8055462
N Engl J Med. 2018 Aug 23;379(8):722-730
pubmed: 30134131
NPJ Precis Oncol. 2017 Sep 18;1(1):33
pubmed: 29872714